Trial Profile
Safety and efficacy of Triptorelin (Gonadotropin-Releasing Hormone Agonist) in Gender Dysphoric Adolescents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2017
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Dysphoria; Sexual and gender disorders
- Focus Therapeutic Use
- 25 Jul 2017 New trial record